-
FDA approves Aurobindo’s Micardis HCT generic
SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Micardis HCT (telmisartan and hydrochlorothiazide) tablets, the company announced Friday.The drug is indicated to treat hypertension and had a market size of $81.9 million for the 12 months ended November 2016, according to QuintilesIMS data.FDA approves Aurobindo’s Geodon generic
SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Geodon (ziprasidone HCl) capsules, the company announced Wednesday. The drug is indicated to treat schizophrenia.Aurobindo’s generic will be available in 20-, 40-, 60- and 80-mg dosage strengths. The drug has an estimated market size of $117 million for the 12 months ended November 2016, according to QuintilesIMS.